Related Experiment Video
Updated: May 15, 2025

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
Published on: September 15, 2018
Dysfunctional HDL Promotes Platelet Apoptosis and Thrombosis in Familial Hypercholesterolemia
In familial hypercholesterolemia (FH), high-density lipoprotein (HDL) becomes prothrombotic, increasing platelet dysfunction and thrombosis risk. A lipid peroxidation scavenger, 2-hydroxybenzylamine (2-HOBA), effectively reverses these effects, offering a potential therapeutic strategy for FH patients.
Area of Science:
- Cardiovascular Biology
- Lipid Metabolism
- Thrombosis Research
Background:
- Familial hypercholesterolemia (FH) is associated with dysfunctional high-density lipoprotein (HDL) enriched in lipid peroxidation products.
- This dysfunctional HDL may contribute to increased thrombotic risk, but its precise impact on platelet function and thrombosis is not fully understood.
- The potential for targeting HDL oxidation to restore its protective functions remains an open question.
Purpose of the Study:
- To investigate the effects of HDL from familial hypercholesterolemia (FH) patients on platelet activation and apoptosis.
- To determine if targeting HDL oxidation can mitigate prothrombotic effects in FH.
- To explore the role of scavenger receptor class B type 1 (SR-B1) and cluster of differentiation 36 (CD36) in HDL-mediated platelet responses.
Main Methods:
- Platelet function analysis using flow cytometry, transmission electron microscopy (TEM), western blotting, and transcriptome analysis.
- Evaluation of HDL effects on oxidized low-density lipoprotein (oxLDL)-induced platelet activation and apoptosis.
- In vivo thrombosis studies in LDL-receptor-deficient (Ldlr-/-) mice treated with 2-hydroxybenzylamine (2-HOBA), a lipid peroxidation scavenger.
Main Results:
- Platelets from FH subjects exhibited heightened activity, increased apoptosis, and altered pro- and anti-apoptotic protein levels compared to healthy controls.
- HDL from healthy individuals inhibited oxLDL-induced platelet activation and apoptosis, while FH-HDL exacerbated these effects.
- Treatment with 2-HOBA improved thrombosis outcomes and blood flow in Ldlr-/- mice, and blocking CD36 prevented the pro-apoptotic effects of FH-HDL.
Conclusions:
- Dysfunctional HDL in FH promotes platelet activation and apoptosis, contributing to a prothrombotic state.
- Targeting HDL oxidation with agents like 2-HOBA can restore HDL's protective functions and mitigate thrombosis risk in FH.
- CD36 plays a significant role in mediating the pro-thrombotic effects of dysfunctional FH-HDL.
Related Concept Videos
Cholesterol: Significance and Regulation
Considering cholesterol and...
Inflammation
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Clot Retraction and Fibrinolysis
Lipid-derived Compounds in the Human Body
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.

